ID   293-VnR
AC   CVCL_M907
SY   HEK-293VnR; HEK293VnR; 293VnR; 293-15D
DR   BTO; BTO:0005839
DR   Wikidata; Q54583911
RX   Patent=US5578704;
RX   Patent=US5652110;
RX   PubMed=7683273;
CC   Transfected with: HGNC; 6150; ITGAV.
CC   Transfected with: HGNC; 6156; ITGB3.
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 07-09-18; Version: 8
//
RX   Patent=US5578704;
RA   Kim K.J., Horton M.A., Bodary S.C., Chuntharapai A.;
RT   "Antibody to osteoclast alphaVbeta3 integrin.";
RL   Patent number US5578704, 26-Nov-1996.
//
RX   Patent=US5652110;
RA   Kim K.J., Horton M.A., Bodary S.C., Chuntharapai A.;
RT   "Antibodies to alpha-V-beta-3 integrin.";
RL   Patent number US5652110, 29-Jul-1997.
//
RX   PubMed=7683273; DOI=10.1006/excr.1993.1096;
RA   Chuntharapai A., Bodary S.C., Horton M.A., Kim K.J.;
RT   "Blocking monoclonal antibodies to alpha V beta 3 integrin: a unique
RT   epitope of alpha V beta 3 integrin is present on human osteoclasts.";
RL   Exp. Cell Res. 205:345-352(1993).
//